Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trial
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Wiley
2019
|